Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Completed · Phase 3 · Has a placebo group

Conditions studied: Motion Sickness

In brief

A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in subjects affected by motion sickness during travel

Key facts

Study ID

NCT04327661

Run by

Vanda Pharmaceuticals

People needed

366

Starts

2021-11-15

Expected to finish

2023-04-12

Last updated by the study team

2024-12-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of motion sickness
• Age 18-75

You may not qualify if…

• Nausea-inducing disorder other than motion sickness
• BMI>40
• History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists

Where it is running

• Pacific Research Network, LLC — San Diego, California, United States
• Santa Monica Clinical Trials — Santa Monica, California, United States
• Gulfcoast Psychiatric Associates — Fort Myers, Florida, United States
• Harmony Clinical Research — North Miami Beach, Florida, United States
• Avita Clinical Research — Tampa, Florida, United States
• Beacon Clinical Research — Quincy, Massachusetts, United States
• Manhattan Medical Research — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.